SpectrumAi, a Los Angeles-based health tech start-up, has secured $20 million in Series A funding to support the development of innovative solutions for life-changing therapies. Investors in the funding round include CVS Health Ventures, F-Prime Capital, Frist Cressey Ventures, AIF, and Cobalt Ventures.

One of SpectrumAi's solutions is Twyll, a next-generation electronic health record (EHR) that modernizes Applied Behavior Analysis (ABA) therapy. Twyll uses data-driven tools to promote progress and measure objective outcomes. Another solution is Patterns ABA network analytics, which closes the circle on objective data and analytics, enabling the transition to value-based contracting.

SpectrumAi's cutting-edge technology is expected to impact the wellness and fitness services industry significantly.

The funding will help SpectrumAi continue its mission of driving innovation in life-changing therapies and improving patient outcomes. Visit Founder lodges latest round for SpectrumAi: https://founderlodge.com/round/SpectrumAi-USA-raises-20000000-Series-A-2023-03-17-Ling-Shao-MTEwMzA